At baseline, total adipose tissue (TAT) ratio was higher among pwCF with prior CFTR modulator therapy, but these differences did not reach statistical significance (+ 37.73%, p = 0.054).
← all excerpts
Elexacaftor/tezacaftor/ivacaftor influences body composition in adults with cystic fibrosis: a fully automated CT-based analysis.
1
0.0540
0.0540